Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I Study of Centhaquin in Healthy Volunteers
NCT02408731Phase 1Completed
- Sponsor
- Pharmazz, Inc.
- Start
- Oct 2014
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of centhaquine in hypovolemic shock (7 arms), sponsored by Pharmazz, Inc. Primary endpoint: Number of Participants with Adverse Events as a Measure of Safety and Tolerability at 7 days. Started Oct 2014; status: completed.
02
Drugs
centhaquine
03
Conditions
hypovolemic shock
Beyond the preview
Go deeper on NCT02408731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02408731.